NICHD Health Research Board Of Ireland Neural Tube Defects Study
NICHD 爱尔兰健康研究委员会神经管缺陷研究
基本信息
- 批准号:8736860
- 负责人:
- 金额:$ 20.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:2p132q129q34AffectAgeAllelesAntigensAreaBiochemicalBiologicalBrachyury proteinCDKN2A geneCandidate Disease GeneCatechol O-MethyltransferaseChemicalsChromosomesChromosomes, Human, Pair 2Cleaved cellCollaborationsComplexComplex Genetic TraitConfidence IntervalsCongenital AbnormalityCongenital Heart DefectsCongenital omphaloceleDataData SetDown SyndromeEnvironmental Risk FactorEpidemiologyEpigenetic ProcessErythrocytesEuropeEvaluationExhibitsFaceFactor VIII-Related AntigenFamilyFathersFolateFolic AcidFortified FoodFrequenciesFutureGene MutationGenesGeneticGenetic DeterminismGenetic PolymorphismGenetic VariationGenotypeGlycoproteinsGoalsHaplotypesHealthHemorrhageHeritabilityHumanIndividualInvestigationIrelandJointsLinear RegressionsMTHFR geneMeasuresMetabolic PathwayMetabolismMethylationMicronutrientsMinorModelingMothersMyocardial InfarctionNational Institute of Child Health and Human DevelopmentNeural Tube DefectsObesityOralPDGFRA geneParentsPathway interactionsPlasmaPopulationPregnancyProperdinPublishingRelative RisksReportingResearchRiskRisk FactorsSample SizeSamplingSerumSiblingsSignal TransductionSingle Nucleotide PolymorphismSpinal DysraphismStrokeStructureStudentsSupplementationTestingThrombosisTriad Acrylic ResinVariantbasecase controlcohortcollegefolic acid metabolismfollow-upgenetic associationgenetic linkage analysisgenetic risk factorgenetic variantgenome wide association studygenome-wideinterestleptin receptormouse modeloral cleftpromotertraittransmission processvolunteervon Willebrand Factor
项目摘要
The Epidemiology Branch is conducting a number of birth defect studies in collaboration with the Health Research Board and Trinity College, Dublin, Ireland. The main objective of these studies is to determine the relationship between folate and birth defects. The birth defects studied to date are neural tube defects (NTDs), oral clefts, congenital heart defects, Down syndrome and omphalocele. These studies focus on biochemical factors in the area of folate metabolism, and on genetic mutations in folate related genes associated with birth defects.
Individual studies of the genetics of neural tube defects (NTDs) contain results on a small number of genes in each report. To identify genetic risk factors for NTDs, we evaluated potentially functional single nucleotide polymorphisms (SNPs) that are biologically plausible risk factors for NTDs but that have never been investigated for an association with NTDs, examined SNPs that previously showed no association with NTDs in published studies, and tried to confirm previously reported associations in folate-related and non-folate-related genes. We investigated 64 SNPs in 34 genes for association with spina bifida in up to 558 case families (520 cases, 507 mothers, 457 fathers) and 994 controls in Ireland. Case-control and mother-control comparisons of genotype frequencies, tests of transmission disequilibrium, and log-linear regression models were used to calculate effect estimates. Spina bifida was associated with over-transmission of the LEPR (leptin receptor) rs1805134 minor C allele genotype relative risk (GRR): 1.5; 95% confidence interval (CI): 1.0-2.1; P = 0.0264 and the COMT (catechol-O-methyltransferase) rs737865 major T allele (GRR: 1.4; 95% CI: 1.1-2.0; P = 0.0206). After correcting for multiple comparisons, these individual test P-values exceeded 0.05. Consistent with previous reports, spina bifida was associated with MTHFR 677C>T, T (Brachyury) rs3127334, LEPR K109R, and PDGFRA promoter haplotype combinations. The associations between LEPR SNPs and spina bifida suggest a possible mechanism for the finding that obesity is a NTD risk factor. The association between a variant in COMT and spina bifida implicates methylation and epigenetics in NTDs.
Neural tube defects (NTDs) are common birth defects (1 in 1000 pregnancies in the US and Europe) that have complex origins, including environmental and genetic factors. A low level of maternal folate is one well-established risk factor, with maternal periconceptional folic acid supplementation reducing the occurrence of NTD pregnancies by 50-70%. Gene variants in the folate metabolic pathway (e.g., MTHFR rs1801133 (677 C > T) and MTHFD1 rs2236225 (R653Q)) have been found to increase NTD risk. We hypothesized that variants in additional folate/B12 pathway genes contribute to NTD risk.
A tagSNP approach was used to screen common variation in 82 candidate genes selected from the folate/B12 pathway and NTD mouse models. We initially genotyped polymorphisms in 320 Irish triads (NTD cases and their parents), including 301 cases and 341 Irish controls to perform case-control and family based association tests. Significantly associated polymorphisms were genotyped in a secondary set of 250 families that included 229 cases and 658 controls. The combined results for 1441 SNPs were used in a joint analysis to test for case and maternal effects.
Nearly 70 SNPs in 30 genes were found to be associated with NTDs at the p < 0.01 level. The ten strongest association signals (p-value range: 0.0003-0.0023) were found in nine genes (MFTC, CDKN2A, ADA, PEMT, CUBN, GART, DNMT3A, MTHFD1 and T (Brachyury)) and included the known NTD risk factor MTHFD1 R653Q (rs2236225). The single strongest signal was observed in a new candidate, MFTC rs17803441 (OR = 1.61 1.23-2.08, p = 0.0003 for the minor allele). Though nominally significant, these associations did not remain significant after correction for multiple hypothesis testing.
To our knowledge, with respect to sample size and scope of evaluation of candidate polymorphisms, this is the largest NTD genetic association study reported to date. The scale of the study and the stringency of correction are likely to have contributed to real associations failing to survive correction. We have produced a ranked list of variants with the strongest association signals. Variants in the highest rank of associations are likely to include true associations and should be high priority candidates for further study of NTD risk.
Future investigations will explore genetic factors that have been shown to affect micronutrients of interest in our quantitative traits genome wide assocation study. For example, we have measured serum and red cell folate levels in over 2500 student volunteers and have generated genome wide data on their genetic variants. These data sets will be merged to determine the most important genetic factors that influence folate levels controlling for use of folic acid containing supplements and fortified food. These results will inform our investigation of genetic factors that are associated with neural tube defect risk.
In addition we are collaborating with other groups to look for genetic variants that affect levels of other important chemicals. Von Willebrand factor has just been studied. The plasma glycoprotein von Willebrand factor (VWF) exhibits fivefold antigen level variation across the normal human population determined by both genetic and environmental factors. Low levels of VWF are associated with bleeding and elevated levels with increased risk for thrombosis, myocardial infarction, and stroke. To identify additional genetic determinants of VWF antigen levels and to minimize the impact of age and illness-related environmental factors, we performed genome-wide association analysis in two young and healthy cohorts (n = 1,152 and n = 2,310) and identified signals at ABO (P < 7.9E-139) and VWF (P < 5.5E-16), consistent with previous reports. Additionally, linkage analysis based on sibling structure within the cohorts, identified significant signals at chromosome 2q12-2p13 (LOD score 5.3) and at the ABO locus on chromosome 9q34 (LOD score 2.9) that explained 19.2% and 24.5% of the variance in VWF levels, respectively. Given its strong effect, the linkage region on chromosome 2 could harbor a potentially important determinant of bleeding and thrombosis risk. The absence of a chromosome 2 association signal in this or previous association studies suggests a causative gene harboring many genetic variants that are individually rare, but in aggregate common. These results raise the possibility that similar loci could explain a significant portion of the "missing heritability" for other complex genetic traits.
流行病学处正在与卫生研究委员会和爱尔兰都柏林三一学院合作开展一些出生缺陷研究。这些研究的主要目的是确定叶酸和出生缺陷之间的关系。迄今为止研究的出生缺陷包括神经管缺陷(NTDs)、唇裂、先天性心脏缺陷、唐氏综合症和脐膨出。这些研究主要集中在叶酸代谢领域的生化因素,以及与出生缺陷相关的叶酸相关基因的基因突变。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James Mills其他文献
James Mills的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James Mills', 18)}}的其他基金
NICHD Health Research Board Of Ireland Neural Tube Defects Study
NICHD 爱尔兰健康研究委员会神经管缺陷研究
- 批准号:
8351158 - 财政年份:
- 资助金额:
$ 20.89万 - 项目类别:
NICHD Health Research Board Of Ireland Neural Tube Defects Study
NICHD 爱尔兰健康研究委员会神经管缺陷研究
- 批准号:
8941478 - 财政年份:
- 资助金额:
$ 20.89万 - 项目类别:
相似海外基金
Genetic risk factors for Visceral Leishmaniasis in Bihar, India
印度比哈尔邦内脏利什曼病的遗传风险因素
- 批准号:
7285461 - 财政年份:2007
- 资助金额:
$ 20.89万 - 项目类别:
NICHD Health Research Board Of Ireland Neural Tube Defects Study
NICHD 爱尔兰健康研究委员会神经管缺陷研究
- 批准号:
8941478 - 财政年份:
- 资助金额:
$ 20.89万 - 项目类别:
Genetic risk factors for Visceral Leishmaniasis in Bihar, India
印度比哈尔邦内脏利什曼病的遗传风险因素
- 批准号:
7922617 - 财政年份:
- 资助金额:
$ 20.89万 - 项目类别:
Genetic risk factors for Visceral Leishmaniasis in Bihar, India
印度比哈尔邦内脏利什曼病的遗传风险因素
- 批准号:
8134247 - 财政年份:
- 资助金额:
$ 20.89万 - 项目类别:
Genetic risk factors for Visceral Leishmaniasis in Bihar, India
印度比哈尔邦内脏利什曼病的遗传风险因素
- 批准号:
7673883 - 财政年份:
- 资助金额:
$ 20.89万 - 项目类别:
Genetic risk factors for Visceral Leishmaniasis in Bihar, India
印度比哈尔邦内脏利什曼病的遗传风险因素
- 批准号:
8319239 - 财政年份:
- 资助金额:
$ 20.89万 - 项目类别: